Inactive Instrument

Insiders Todos Medical Ltd. Other OTC

Equities

Dorit Arad Joins Todos Medical as Chief Scientific Officer	17/22/17	CI
Todos Medical Appoints Ilanit Halperin as Corporate Controller	07/21/07	CI
Todos Medical announces That It Has Selected the Brand Name “Tollovid™” for Its Proprietary, Patent Protected 3Cl Protease Inhibitor, Previously Called NLC-001	29/20/29	CI
Todos Medical Ltd. Appoints Jorge Leon, Ph.D. as Consulting Chief Medical and Scientific Officer for Infectious Disease and Oncology	04/20/04	CI
Todos Medical Ltd. Announces Management Appointments	20/20/20	CI
Todos Medical Ltd. Appoints Lauren Chung to Its Board of Directors	17/20/17	CI
Todos Medical Ltd. Announces Management Changes	06/20/06	CI
Todos Medical Ltd. Announces Management Changes	03/20/03	CI
Todos Medical Ltd. Announces Resignation of Colin Bier from Board of Directors	07/19/07	CI
Todos Medical Ltd. Appoints Jorge Leon as Medical Advisor	07/19/07	CI
Todos Medical Ltd. Appoints Colin Bier to its Board of Directors	27/19/27	CI
Todos Medical Ltd. Announces Management Changes	31/18/31	CI
Todos Medical, Ltd. Appoints David Ben Naim as CFO	06/18/06	CI
Todos Medical Limited Announces Resignation of Shlomo Zakai as Chief Financial Officer, with Effect from December 15, 2017	24/17/24	CI
Todos Medical Limited Appoints Meir Silver as Vice President of Clinical Research and Regulatory Affairs	29/17/29	CI
Todos Medical Ltd. Announces Board Changes	27/17/27	CI

No results for this search